HDAC3 degradation to uncover therapeutic vulnerability in colorectal cancer.
Overcoming therapeutic resistance in colorectal cancer (CRC) remains a major clinical challenge, highlighting the need for strategies targeting epigenetic drivers. Targeted protein degradation emerged as a powerful approach to selectively eliminate disease-relevant proteins. We reported the development of two series of...